KR101113163B1 - 스타틴, 특히 아토르바스타틴의 제조에 유용한 중간체화합물 및 그 제조방법 - Google Patents

스타틴, 특히 아토르바스타틴의 제조에 유용한 중간체화합물 및 그 제조방법 Download PDF

Info

Publication number
KR101113163B1
KR101113163B1 KR1020067000774A KR20067000774A KR101113163B1 KR 101113163 B1 KR101113163 B1 KR 101113163B1 KR 1020067000774 A KR1020067000774 A KR 1020067000774A KR 20067000774 A KR20067000774 A KR 20067000774A KR 101113163 B1 KR101113163 B1 KR 101113163B1
Authority
KR
South Korea
Prior art keywords
group
compound
formula
general formula
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020067000774A
Other languages
English (en)
Korean (ko)
Other versions
KR20060040679A (ko
Inventor
데이비드 존 무디
조나단 윌리엄 위픈
Original Assignee
브래드포드 파마 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0317393A external-priority patent/GB0317393D0/en
Priority claimed from GB0406760A external-priority patent/GB0406760D0/en
Application filed by 브래드포드 파마 리미티드 filed Critical 브래드포드 파마 리미티드
Publication of KR20060040679A publication Critical patent/KR20060040679A/ko
Application granted granted Critical
Publication of KR101113163B1 publication Critical patent/KR101113163B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyrane Compounds (AREA)
KR1020067000774A 2003-07-25 2004-07-23 스타틴, 특히 아토르바스타틴의 제조에 유용한 중간체화합물 및 그 제조방법 Expired - Fee Related KR101113163B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0317393.7 2003-07-25
GB0317393A GB0317393D0 (en) 2003-07-25 2003-07-25 Process and compounds
GB0406760A GB0406760D0 (en) 2004-03-26 2004-03-26 Process and compounds
GB0406760.9 2004-03-26
PCT/GB2004/003206 WO2005012246A1 (en) 2003-07-25 2004-07-23 Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin

Publications (2)

Publication Number Publication Date
KR20060040679A KR20060040679A (ko) 2006-05-10
KR101113163B1 true KR101113163B1 (ko) 2012-02-17

Family

ID=34117641

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067000774A Expired - Fee Related KR101113163B1 (ko) 2003-07-25 2004-07-23 스타틴, 특히 아토르바스타틴의 제조에 유용한 중간체화합물 및 그 제조방법

Country Status (11)

Country Link
US (2) US7414141B2 (https=)
EP (2) EP1648866A1 (https=)
JP (1) JP4820965B2 (https=)
KR (1) KR101113163B1 (https=)
AU (1) AU2004261468B2 (https=)
BR (1) BRPI0412786A (https=)
CA (1) CA2530163C (https=)
HR (1) HRP20051020A2 (https=)
IL (1) IL173012A (https=)
NO (1) NO335650B1 (https=)
WO (1) WO2005012246A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1671947A1 (en) * 2004-12-20 2006-06-21 Ratiopharm GmbH Process for preparing pyrrole derivatives and intermediates
DE102005022284A1 (de) * 2005-05-13 2006-11-23 Ratiopharm Gmbh Verfahren zur Herstellung von Statinen
WO2009019561A2 (en) * 2007-08-03 2009-02-12 Pfizer Products Inc. Process for preparing chiral compounds
AU2013202895B2 (en) * 2009-03-10 2014-09-18 Redx Pharma Plc Rosuvastatin and atorvastatin derivatives
GB0904102D0 (en) * 2009-03-10 2009-04-22 Bradford Pharma Ltd Use of atorvastatin lactols as medicaments
GB0904104D0 (en) * 2009-03-10 2009-04-22 Bradford Pharma Ltd Atorvastatin and rosuvastatin derivatives
GB0904100D0 (en) * 2009-03-10 2009-04-22 Bradford Pharma Ltd Use of rosuvastatin lactols as medicaments

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006968A1 (en) * 1990-10-17 1992-04-30 Warner-Lambert Company Process for the synthesis of (4r-cis)-1,1-dimethylethyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
WO2004096788A1 (en) 2003-05-02 2004-11-11 Dsm Ip Assets B.V. Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US5003080A (en) 1988-02-22 1991-03-26 Warner-Lambert Company Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5298627A (en) * 1993-03-03 1994-03-29 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
US5385929A (en) * 1994-05-04 1995-01-31 Warner-Lambert Company [(Hydroxyphenylamino) carbonyl] pyrroles
US5795749A (en) 1995-04-05 1998-08-18 The Scripps Research Institution Use of 2-deoxyribose-5-phosphate aldolase to prepare 2-deoxyfucose, analogues and derivatives
DE10131522A1 (de) * 2001-07-02 2003-01-16 Creavis Tech & Innovation Gmbh Verfahren zur Herstellung gesättigter Alkohole, Ketone, Aldehyde und Carbonsäuren
HRPK20040255B3 (en) * 2001-08-16 2006-02-28 Teva Pharmaceutical Industries Ltd. Processes for preparing calcium salt forms of statins
US7078430B2 (en) 2002-07-08 2006-07-18 Ranbaxy Laboratories Limited HMG CoA-reductase inhibitors
AU2003263031A1 (en) * 2002-09-20 2004-04-08 Diversa Corporation Chemoenzymatic methods for the synthesis of statins and stain intermediates
JP2006523670A (ja) 2003-04-14 2006-10-19 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー 5−(4−フルオロフェニル)−1−[2−((2r,4r)−4−ヒドロキシ−6−オキソ−テトラヒドロ−ピラン−2−イル)エチル]−2−イソプロピル−4−フェニル−1h−ピロール−3−カルボン酸フェニルアミドの調製方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006968A1 (en) * 1990-10-17 1992-04-30 Warner-Lambert Company Process for the synthesis of (4r-cis)-1,1-dimethylethyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
WO2004096788A1 (en) 2003-05-02 2004-11-11 Dsm Ip Assets B.V. Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof

Also Published As

Publication number Publication date
US7414141B2 (en) 2008-08-19
CA2530163C (en) 2012-10-02
KR20060040679A (ko) 2006-05-10
EP2522656A3 (en) 2013-03-20
US8614335B2 (en) 2013-12-24
WO2005012246A1 (en) 2005-02-10
JP4820965B2 (ja) 2011-11-24
CA2530163A1 (en) 2005-02-10
JP2006528655A (ja) 2006-12-21
EP2522656A2 (en) 2012-11-14
US20070043221A1 (en) 2007-02-22
AU2004261468A1 (en) 2005-02-10
HRP20051020A2 (hr) 2006-04-30
NO335650B1 (no) 2015-01-19
IL173012A (en) 2015-05-31
US20090062553A1 (en) 2009-03-05
NO20060903L (no) 2005-01-26
AU2004261468B2 (en) 2011-04-14
IL173012A0 (en) 2006-06-11
BRPI0412786A (pt) 2006-09-26
EP1648866A1 (en) 2006-04-26

Similar Documents

Publication Publication Date Title
US8614335B2 (en) Process and intermediates useful in the preparation of statins, particularly atorvastatin
JP5016478B2 (ja) スタチン類、特にロスバスタチンの調製に有用な方法および中間化合物
JP2007513077A (ja) スタチン類の製造方法
KR100881617B1 (ko) 아토바스타틴 제조를 위한 중간체 및 그의 제조방법
KR20120001306A (ko) 티오에스터 화합물, 술폰 화합물 및 이를 이용한 피타바스타틴 또는 이의 약제학적으로 허용 가능한 염의 제조방법
CN100503565C (zh) 用于制备他汀类尤其是阿托伐他汀的方法和中间化合物
CA2601111A1 (en) Preparation of an atorvastatin intermediate using a paal-knorr condensation
EP2679580A1 (en) Thioamide compound, method for producing thioamide compound, method for producing [(4r,6r)-6-aminoethyl-1,3-dioxane-4-yl]acetate derivative, and method for producing atorvastatin
JP2006528655A5 (https=)
EP1842847B1 (en) Process for production of 5-chloro-2,4-dihydroxypyridine
KR101130717B1 (ko) HMG-CoA 환원 저해제의 제조를 위한 키랄 중간체의제조방법
JP2005126340A (ja) 置換ピリドン類の製造法、その原料化合物及びその製造方法
US20130345429A1 (en) Process and intermediate compounds useful in the preparation of statins
KR100502833B1 (ko) 심바스타틴 및 이의 중간체 화합물들의 개선된 제조방법
MXPA06000926A (en) Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin
BG107145A (bg) Метод за селективно n-формилиране на n-хидроксиламини
JP5787980B2 (ja) イソセリン誘導体の調製方法
JPH0681734B2 (ja) ビシクロヒユムレノンの製造方法
KR100665794B1 (ko) 4-(4-플루오르페닐)-2-이소부티릴-3-페닐-4-옥소-n-페닐-부틸아미드의 신규한 제조방법
JPH1160513A (ja) シクロプロピルアセチレン誘導体の製造方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20160125

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20170201

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20170201